Fibrosis progression in patients treated for hepatitis C recurrence

Publisher： John Wiley & Sons Inc

E-ISSN： 1478-3231|35|12|2624-2625

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.12, 2015-12, pp. : 2624-2625

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Response to Fibrosis progression in patients treated for hepatitis C recurrence

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 12, 2015-12 ,pp. : 2625-2625

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of fibrosis progression on clinical outcome in patients treated for post‐ transplant hepatitis C recurrence

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 11, 2015-11 ,pp. : 2433-2441

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetic variation in the interleukin‐28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection

By  

HEPATOLOGY, Vol. 54, Iss. 4, 2011-10 ,pp. : 1127-1134

John Wiley & Sons Inc

Access to resources Recommend Favorite

Plasma Pro‐C3 (N‐terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 2, 2015-02 ,pp. : 429-437

John Wiley & Sons Inc

Access to resources Recommend Favorite

Commentary: triple therapy for patients with chronic hepatitis C and advanced fibrosis?

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 11-12, 2013-12 ,pp. : 1407-1408

John Wiley & Sons Inc

Access to resources Recommend Favorite